Addus HomeCare Corp
ADUSNasdaqCIK 1468328HealthcareFiscal year ends Dec 31
Reports and events: 292 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1417:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-030348 |
| 2026-08-1316:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-027682 |
| 2026-08-0416:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-025678 |
| 2026-08-0316:25 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-025448 |
| 2026-06-1016:03 ET | 8-K | 5.07 Shareholder vote results | 0001437749-26-020152 |
| 2026-05-0516:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-014900 |
| 2026-05-0416:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-014653 |
| 2026-04-2316:31 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001437749-26-013190 |
| 2026-03-1216:31 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001437749-26-007982 |
| 2026-02-2416:31 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-005352 |
| 2026-02-2316:16 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-005106 |
| 2025-11-0416:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-033041 |
| 2025-11-0316:36 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-032790 |
| 2025-08-2716:36 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001437749-25-027876 |
| 2025-08-0716:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-025425 |
| 2025-08-0516:31 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-024871 |
| 2025-08-0416:16 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-024617 |
| 2025-06-2316:30 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-089023 |
| 2025-05-0616:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-064522 |
| 2025-05-0516:54 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-112849 |
| 2025-04-2418:00 ET | DEF 14A | Proxy statementPeriod 2025-04-23 | 0000950170-25-057552 |
| 2025-03-1116:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-051953 |
| 2025-02-2516:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-026747 |
| 2025-02-2416:27 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-033454 |
| 2025-02-1417:00 ET | 8-K/A | 9.01 Financial statements and exhibits | 0000950170-25-021397 |
| 2024-12-0216:34 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-268958 |
| 2024-11-0516:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-121448 |
| 2024-11-0416:26 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-250644 |
| 2024-10-2316:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-241868 |
| 2024-08-0616:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-091763 |
| 2024-08-0516:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-193948 |
| 2024-06-2821:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-170947 |
| 2024-06-2616:12 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-24-169048 |
| 2024-06-1216:02 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-159929 |
| 2024-06-1016:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-158317 |
| 2024-05-0716:30 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-054603 |
| 2024-05-0617:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-132042 |
| 2024-04-2416:30 ET | DEF 14A | Proxy statementPeriod 2024-04-22 | 0000950170-24-047625 |
| 2024-04-2317:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-107221 |
| 2024-02-2716:45 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-021284 |
| 2024-02-2616:21 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-046224 |
| 2023-10-3116:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-056903 |
| 2023-10-3016:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-266181 |
| 2023-08-0117:06 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-200641 |
| 2023-08-0116:31 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-036509 |
| 2023-07-3116:39 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-199181 |
| 2023-06-2908:03 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-178048 |
| 2023-06-1516:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-167873 |
| 2023-05-0216:31 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-016717 |
| 2023-05-0117:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-130662 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.